This diagnostic image is an endovaginal ultrasound of a human ovary, commonly associated with the diagnosis of polycystic ovary syndrome (PCOS). The ultrasound shows a transverse cross-section of the ovary characterized by an increased volume and specific follicular distribution. Numerous small, hypoechoic to anechoic cystic structures (follicles), typically measuring 2–8 mm in diameter, are visible. These follicles are arranged in a classic subcapsular distribution, lining up along the periphery of the organ to create the characteristic 'string-of-pearls' sign. The central portion of the ovary consists of a prominent, hyper-echodense ovarian stroma, which appears brighter relative to the dark peripheral cysts. This imaging pattern is a hallmark sonographic criterion for PCOS in the context of clinical signs like hirsutism or metabolic dysfunction. An inset image in the bottom right corner provides a visual analogy using a literal string of pearls to illustrate the diagnostic pattern.

This diagnostic image is a B-mode ultrasound scan of a human ovary, demonstrating characteristic features of Polycystic Ovary Syndrome (PCOS). The image shows multiple hypoechoic (dark) regions representing ovarian follicles. Two specific regions are labeled 'A' and 'B'. Region A is a rounded, anechoic structure marked with measurement calipers to determine follicle size. Region B is a larger, more elongated hypoechoic area situated lower in the stroma. The image quality is characterized by low contrast and significant speckle noise, which is typical for raw clinical ultrasound data before digital enhancement. These factors result in poorly defined follicle boundaries that blend into the surrounding echogenic ovarian stroma. The educational focus of this image is on the visual identification and manual measurement of follicles for PCOS diagnosis, highlighting the technical challenges in distinguishing fluid-filled cysts from adjacent tissue and pelvic capillaries in low-light-intensity ultrasound captures.

This diagnostic image is a side-by-side transvaginal ultrasound (sonography) displaying the right and left ovaries in a 31-year-old female patient on day 2 of her menstrual cycle. The modality is gray-scale ultrasound, showing transverse or longitudinal views of the pelvic adnexa. Both ovaries demonstrate significant polycystic morphology, characterized by an increased number of small, peripherally arranged follicles and a dense stroma. The right ovary shows multiple scattered anechoic (dark) cysts, while the left ovary displays a more crowded, classic 'string of pearls' or honeycomb appearance with densely packed fluid-filled follicles. These findings are consistent with the clinical diagnosis of Polycystic Ovary Syndrome (PCOS). The image labels highlight specific cystic structures within the enlarged ovarian volume. The educational focus is on identifying diagnostic sonographic criteria for PCOS, including follicular count, size, and distribution within the ovarian stroma during a clinical evaluation for symptoms like irregular cycles and hirsutism.

Two diagnostic ultrasound images of the pelvic region demonstrate the classical sonographic findings of Polycystic Ovary Syndrome (PCOS). The images show bilateral ovarian enlargement, with the right ovary measuring 14 ml and the left ovary measuring 17 ml. Both ovaries exhibit a characteristic distribution of multiple small, subcentimeter, hypoechoic follicles located at the periphery, creating a 'string of pearls' appearance. There is a notable increase in the central echogenicity and volume of the ovarian stroma, termed stromal hyperplasia or prominent stroma. These visual features are consistent with the Rotterdam criteria for polycystic ovary morphology in a clinical context of hyperandrogenism. This image serves as an educational reference for identifying gynecological pathology through ultrasonography, specifically highlighting morphological changes in the adnexa associated with endocrine disorders like PCOS and ovarian hyperthecosis.

This pathophysiology diagram illustrates the dysregulation of the Androgen Receptor (AR) signaling pathway in the gravid uterus under conditions of hyperandrogenism and insulin resistance. A temporal comparison at the top shows that in normal pregnancy, AR expression transitions from moderate (yellow) during pre-implantation and implantation to low (black) post-implantation. In contrast, hyperandrogenism + insulin resistance maintains sustained high (red) AR expression across all stages. The cellular model depicts high AR expression (red star symbols) localized within the nucleus, cytoplasm, and mitochondrion. Nuclear AR translocation affects the transcription of implantation-related genes, including p21WAF1/CIP1, Spp1, Igfbp1, and Hoxa11, as well as Nr2f2, Ptch, Pgr, and Hbegf. Concurrently, mitochondrial AR localization and interaction with OXPHOS (Complex I/III), VDAC, PHB1, and Nrf1 contribute to mitochondrial malfunction. These combined molecular disturbances lead to abnormal implantation, compromised pregnancy outcomes, and subfertility, modeling mechanisms often associated with Polycystic Ovary Syndrome (PCOS).

This pathophysiology diagram illustrates the differential regulation of inositol metabolism in classic insulin-responsive tissues versus the ovaries in Polycystic Ovary Syndrome (PCOS) with insulin resistance (IR). The top panel compares healthy and PCOS states in peripheral tissues. In healthy individuals, insulin binding to the insulin receptor activates the epimerase enzyme, facilitating the conversion of myo-inositol (MI) to D-chiro-inositol (DCI). In PCOS with IR, this conversion is blocked (indicated by an 'X'), leading to a 'Deficiency of DCI'. The bottom panel depicts the 'ovarian paradox'. In the ovary of a patient with PCOS and IR, hyperinsulinemia overstimulates the insulin receptor and the epimerase enzyme (indicated by a plus sign and thick arrows). This overactivity causes an excessive conversion of MI to DCI, resulting in a 'Pathological Increase of DCI'. The diagram uses chemical structures for MI and DCI and flow-based signaling pathways to explain how metabolic dysregulation in PCOS leads to tissue-specific inositol imbalances, contributing to endocrine dysfunction.

A pathophysiology diagram illustrating the clinical impact of a Low-Calorie Ketogenic Diet (LCKD) protocol on adolescents with Polycystic Ovary Syndrome (PCOS). The schematic follows a linear progression from left to right. It begins with an adolescent figure representing a PCOS diagnosis, highlighting the pelvic region. The next stage depicts the 'LCKD protocol' intervention, which leads to the biochemical phase of 'Ketone bodies production,' represented by a molecular model. The final section branches into multiple physiological benefits, categorized by icons: a scale indicating weight loss and body composition improvement; a liver icon for lipid profile improvement; a blood drop for reduction in insulin resistance and oxidative stress; a calendar for menstrual regularity and hirsutism improvement; and a reproductive system icon for the reduction of androgen levels and LH/FSH ratios, alongside improved ovarian function. This infographic summarizes the multi-systemic metabolic and endocrine benefits of nutritional ketosis in managing PCOS symptoms.